CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- Open-market buys, last 90 days
- $5,000,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,000,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-27 | White Mark K. Director | Grant or award · Stock Option (right to buy) | +2,146 | 2,146 | ||
| 2023-11-20 | White Mark K. Director | Grant or award | +1,990 | $6.10 | $12K | 61,167 |
| 2023-11-20 | McCarthy Reid Director | Other acquisition | +0 | 7,305 | ||
| 2023-11-20 | Hoffman Michael B Director | Grant or award | +163,880 | $6.10 | $1000K | 223,357 |
| 2023-11-20 | Maccecchini Maria-Luisa President and CEO | Grant or award | +40,970 | $6.10 | $250K | 1,098,459 |
| 2023-11-20 | Hagopian Henry III Chief Financial Officer | Grant or award | +820 | $6.10 | $5K | 1,820 |
| 2023-11-20 | Bruck Claudine Director | Other acquisition | +0 | 6,567 | ||
| 2023-11-20 | McCarthy Reid Director | Grant or award | +824 | $6.07 | $5K | 8,129 |
| 2023-11-20 | Hoffman Michael B Director | Grant or award | +164,745 | $6.07 | $1.0M | 224,222 |
| 2023-11-20 | White Mark K. Director | Grant or award | +2,000 | $6.07 | $12K | 61,177 |
| 2023-11-20 | Maccecchini Maria-Luisa President and CEO | Grant or award | +41,186 | $6.07 | $250K | 1,098,675 |
| 2023-11-20 | Hagopian Henry III Chief Financial Officer | Grant or award | +824 | $6.07 | $5K | 1,824 |
| 2023-11-20 | Bruck Claudine Director | Grant or award | +1,000 | $6.07 | $6K | 7,567 |
| 2023-11-17 | White Mark K. Director | Grant or award · Stock Option (right to buy) | +26,200 | 26,200 | ||
| 2023-11-17 | McCarthy Reid Director | Grant or award · Stock Option (right to buy) | +29,600 | 29,600 | ||
| 2023-11-17 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +252,000 | 252,000 | ||
| 2023-11-17 | Maccecchini Maria-Luisa President and CEO | Grant or award · Stock Option (right to buy) | +108,800 | 108,800 | ||
| 2023-11-17 | Hoffman Michael B Director | Grant or award · Stock Option (right to buy) | +29,600 | 29,600 | ||
| 2023-11-17 | Bruck Claudine Director | Grant or award · Stock Option (right to buy) | +26,200 | 26,200 | ||
| 2023-04-24 | Maccecchini Maria-Luisa President and CEO | Gift | −3,000 | 1,057,489 |
Page 3 of 8 · 142 trades